Clinical trial · Interventional
Virtual Reality-Based Exercise in Cancer Patients
Virtual Reality-Based Exercise in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the present study is to evaluate an innovative virtual reality-based balance training intervention for improving clinically relevant motor performances (balance and gait) in cancer patients. The investigators hypothesize that the virtual reality-based balance training intervention will improve balance and gait performances in cancer patients compared to a control group receiving usual care only.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Distorted; Balance | — | UNRESOLVED | — |
| Motor Deficit | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Balance Training | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Balance Training
- description
- Balance training will be conducted individually two times per week for 4 weeks. Each training session will include virtual reality tasks such as "ankle reaching" and "obstacle crossing" using a virtual obstacle shown on a computer screen. Each session will last 30 - 45 minutes.
- interventionNames
- Other: Balance Training
- type
- NO_INTERVENTION
- label
- Control
- description
- The control group will keep their normal activity without receiving any intervention.
Primary outcomes (1)
- measure
- Postural Balance
- timeFrame
- after 4 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * ability to ambulate without assistance * willingness to provide informed consent * cancer * neuropathy related to chemotherapy Exclusion Criteria: * severe neurologic, cardiovascular, metabolic, or psychiatric disorders * severe visual impairment * cognitive impairment
References
Publications (0)
Data not yet available